Global Candidiasis Therapeutics Market Research Report 2025(Status and Outlook)
Report Overview
The market for Candidiasis Therapeutics focuses on the treatment of infections caused by Candida species, which are opportunistic fungal pathogens affecting immunocompromised individuals, diabetics, and those undergoing prolonged antibiotic therapy. Infections range from superficial mucosal conditions like oral thrush and vaginal yeast infections to life-threatening systemic candidiasis, particularly in hospitalized patients. The therapeutics market includes antifungal drugs such as azoles (e.g., fluconazole, itraconazole), polyenes (e.g., amphotericin B), echinocandins (e.g., caspofungin), and newer agents addressing drug-resistant strains. Increasing antifungal resistance, rising immunocompromised populations (due to HIV, cancer therapies, and organ transplants), and expanding diagnostic capabilities drive demand. The market is also shaped by generic competition, pipeline innovations, and regional variations in infection prevalence and healthcare access.
The global Candidiasis Therapeutics market size was estimated at USD 3312.82 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.23% during the forecast period.
This report provides a deep insight into the global Candidiasis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Candidiasis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Candidiasis Therapeutics market in any manner.
Global Candidiasis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Amgen
F. Hoffmann-La Roche Ltd.
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Ablynx
Genta Incorporated
Galapagos NV
Catena Pharmaceuticals Inc.
Digna Biotech S.L.
Medivir AB
Amura Holdings
Market Segmentation (by Type)
Doxorubicin
Cisplatin
7Carboplatin
Etoposide
Ifosfamide
Cyclophosphamide
Methotrexate
Vincristine
Market Segmentation (by Application)
Multispecialty Hospitals
Cancer Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Candidiasis Therapeutics Market
Overview of the regional outlook of the Candidiasis Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Candidiasis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Candidiasis Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The market for Candidiasis Therapeutics focuses on the treatment of infections caused by Candida species, which are opportunistic fungal pathogens affecting immunocompromised individuals, diabetics, and those undergoing prolonged antibiotic therapy. Infections range from superficial mucosal conditions like oral thrush and vaginal yeast infections to life-threatening systemic candidiasis, particularly in hospitalized patients. The therapeutics market includes antifungal drugs such as azoles (e.g., fluconazole, itraconazole), polyenes (e.g., amphotericin B), echinocandins (e.g., caspofungin), and newer agents addressing drug-resistant strains. Increasing antifungal resistance, rising immunocompromised populations (due to HIV, cancer therapies, and organ transplants), and expanding diagnostic capabilities drive demand. The market is also shaped by generic competition, pipeline innovations, and regional variations in infection prevalence and healthcare access.
The global Candidiasis Therapeutics market size was estimated at USD 3312.82 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.23% during the forecast period.
This report provides a deep insight into the global Candidiasis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Candidiasis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Candidiasis Therapeutics market in any manner.
Global Candidiasis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Amgen
F. Hoffmann-La Roche Ltd.
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Ablynx
Genta Incorporated
Galapagos NV
Catena Pharmaceuticals Inc.
Digna Biotech S.L.
Medivir AB
Amura Holdings
Market Segmentation (by Type)
Doxorubicin
Cisplatin
7Carboplatin
Etoposide
Ifosfamide
Cyclophosphamide
Methotrexate
Vincristine
Market Segmentation (by Application)
Multispecialty Hospitals
Cancer Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Candidiasis Therapeutics Market
Overview of the regional outlook of the Candidiasis Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Candidiasis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Candidiasis Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Candidiasis Therapeutics
1.2 Key Market Segments
1.2.1 Candidiasis Therapeutics Segment by Type
1.2.2 Candidiasis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANDIDIASIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Candidiasis Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Candidiasis Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANDIDIASIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Candidiasis Therapeutics Product Life Cycle
3.3 Global Candidiasis Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Candidiasis Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Candidiasis Therapeutics Market Competitive Situation and Trends
3.8.1 Candidiasis Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANDIDIASIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Candidiasis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANDIDIASIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Candidiasis Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Candidiasis Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Candidiasis Therapeutics Price by Type (2020-2025)
7 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Candidiasis Therapeutics Market Sales by Application (2020-2025)
7.3 Global Candidiasis Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
8 CANDIDIASIS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Candidiasis Therapeutics Sales by Region
8.1.1 Global Candidiasis Therapeutics Sales by Region
8.1.2 Global Candidiasis Therapeutics Sales Market Share by Region
8.2 Global Candidiasis Therapeutics Market Size by Region
8.2.1 Global Candidiasis Therapeutics Market Size by Region
8.2.2 Global Candidiasis Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Candidiasis Therapeutics Sales by Country
8.3.2 North America Candidiasis Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Candidiasis Therapeutics Sales by Country
8.4.2 Europe Candidiasis Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Candidiasis Therapeutics Sales by Region
8.5.2 Asia Pacific Candidiasis Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Candidiasis Therapeutics Sales by Country
8.6.2 South America Candidiasis Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Candidiasis Therapeutics Sales by Region
8.7.2 Middle East and Africa Candidiasis Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANDIDIASIS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Candidiasis Therapeutics by Region(2020-2025)
9.2 Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Candidiasis Therapeutics Production
9.4.1 North America Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Candidiasis Therapeutics Production
9.5.1 Europe Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Candidiasis Therapeutics Production (2020-2025)
9.6.1 Japan Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Candidiasis Therapeutics Production (2020-2025)
9.7.1 China Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis AG
10.1.1 Novartis AG Basic Information
10.1.2 Novartis AG Candidiasis Therapeutics Product Overview
10.1.3 Novartis AG Candidiasis Therapeutics Product Market Performance
10.1.4 Novartis AG Business Overview
10.1.5 Novartis AG SWOT Analysis
10.1.6 Novartis AG Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Candidiasis Therapeutics Product Overview
10.2.3 Amgen Candidiasis Therapeutics Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Basic Information
10.3.2 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd. Business Overview
10.3.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.4 Bayer-Algeta
10.4.1 Bayer-Algeta Basic Information
10.4.2 Bayer-Algeta Candidiasis Therapeutics Product Overview
10.4.3 Bayer-Algeta Candidiasis Therapeutics Product Market Performance
10.4.4 Bayer-Algeta Business Overview
10.4.5 Bayer-Algeta Recent Developments
10.5 Merrion Pharmaceuticals Plc.
10.5.1 Merrion Pharmaceuticals Plc. Basic Information
10.5.2 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
10.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Market Performance
10.5.4 Merrion Pharmaceuticals Plc. Business Overview
10.5.5 Merrion Pharmaceuticals Plc. Recent Developments
10.6 Ablynx
10.6.1 Ablynx Basic Information
10.6.2 Ablynx Candidiasis Therapeutics Product Overview
10.6.3 Ablynx Candidiasis Therapeutics Product Market Performance
10.6.4 Ablynx Business Overview
10.6.5 Ablynx Recent Developments
10.7 Genta Incorporated
10.7.1 Genta Incorporated Basic Information
10.7.2 Genta Incorporated Candidiasis Therapeutics Product Overview
10.7.3 Genta Incorporated Candidiasis Therapeutics Product Market Performance
10.7.4 Genta Incorporated Business Overview
10.7.5 Genta Incorporated Recent Developments
10.8 Galapagos NV
10.8.1 Galapagos NV Basic Information
10.8.2 Galapagos NV Candidiasis Therapeutics Product Overview
10.8.3 Galapagos NV Candidiasis Therapeutics Product Market Performance
10.8.4 Galapagos NV Business Overview
10.8.5 Galapagos NV Recent Developments
10.9 Catena Pharmaceuticals Inc.
10.9.1 Catena Pharmaceuticals Inc. Basic Information
10.9.2 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
10.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Market Performance
10.9.4 Catena Pharmaceuticals Inc. Business Overview
10.9.5 Catena Pharmaceuticals Inc. Recent Developments
10.10 Digna Biotech S.L.
10.10.1 Digna Biotech S.L. Basic Information
10.10.2 Digna Biotech S.L. Candidiasis Therapeutics Product Overview
10.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product Market Performance
10.10.4 Digna Biotech S.L. Business Overview
10.10.5 Digna Biotech S.L. Recent Developments
10.11 Medivir AB
10.11.1 Medivir AB Basic Information
10.11.2 Medivir AB Candidiasis Therapeutics Product Overview
10.11.3 Medivir AB Candidiasis Therapeutics Product Market Performance
10.11.4 Medivir AB Business Overview
10.11.5 Medivir AB Recent Developments
10.12 Amura Holdings
10.12.1 Amura Holdings Basic Information
10.12.2 Amura Holdings Candidiasis Therapeutics Product Overview
10.12.3 Amura Holdings Candidiasis Therapeutics Product Market Performance
10.12.4 Amura Holdings Business Overview
10.12.5 Amura Holdings Recent Developments
11 CANDIDIASIS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Candidiasis Therapeutics Market Size Forecast
11.2 Global Candidiasis Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Candidiasis Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region
11.2.4 South America Candidiasis Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Candidiasis Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Candidiasis Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Candidiasis Therapeutics by Type (2026-2033)
12.1.2 Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Candidiasis Therapeutics by Type (2026-2033)
12.2 Global Candidiasis Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Candidiasis Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Candidiasis Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Candidiasis Therapeutics
1.2 Key Market Segments
1.2.1 Candidiasis Therapeutics Segment by Type
1.2.2 Candidiasis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANDIDIASIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Candidiasis Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Candidiasis Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANDIDIASIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Candidiasis Therapeutics Product Life Cycle
3.3 Global Candidiasis Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Candidiasis Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Candidiasis Therapeutics Market Competitive Situation and Trends
3.8.1 Candidiasis Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANDIDIASIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Candidiasis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANDIDIASIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Candidiasis Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Candidiasis Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Candidiasis Therapeutics Price by Type (2020-2025)
7 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Candidiasis Therapeutics Market Sales by Application (2020-2025)
7.3 Global Candidiasis Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
8 CANDIDIASIS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Candidiasis Therapeutics Sales by Region
8.1.1 Global Candidiasis Therapeutics Sales by Region
8.1.2 Global Candidiasis Therapeutics Sales Market Share by Region
8.2 Global Candidiasis Therapeutics Market Size by Region
8.2.1 Global Candidiasis Therapeutics Market Size by Region
8.2.2 Global Candidiasis Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Candidiasis Therapeutics Sales by Country
8.3.2 North America Candidiasis Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Candidiasis Therapeutics Sales by Country
8.4.2 Europe Candidiasis Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Candidiasis Therapeutics Sales by Region
8.5.2 Asia Pacific Candidiasis Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Candidiasis Therapeutics Sales by Country
8.6.2 South America Candidiasis Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Candidiasis Therapeutics Sales by Region
8.7.2 Middle East and Africa Candidiasis Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANDIDIASIS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Candidiasis Therapeutics by Region(2020-2025)
9.2 Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Candidiasis Therapeutics Production
9.4.1 North America Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Candidiasis Therapeutics Production
9.5.1 Europe Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Candidiasis Therapeutics Production (2020-2025)
9.6.1 Japan Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Candidiasis Therapeutics Production (2020-2025)
9.7.1 China Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis AG
10.1.1 Novartis AG Basic Information
10.1.2 Novartis AG Candidiasis Therapeutics Product Overview
10.1.3 Novartis AG Candidiasis Therapeutics Product Market Performance
10.1.4 Novartis AG Business Overview
10.1.5 Novartis AG SWOT Analysis
10.1.6 Novartis AG Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Candidiasis Therapeutics Product Overview
10.2.3 Amgen Candidiasis Therapeutics Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Basic Information
10.3.2 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd. Business Overview
10.3.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.4 Bayer-Algeta
10.4.1 Bayer-Algeta Basic Information
10.4.2 Bayer-Algeta Candidiasis Therapeutics Product Overview
10.4.3 Bayer-Algeta Candidiasis Therapeutics Product Market Performance
10.4.4 Bayer-Algeta Business Overview
10.4.5 Bayer-Algeta Recent Developments
10.5 Merrion Pharmaceuticals Plc.
10.5.1 Merrion Pharmaceuticals Plc. Basic Information
10.5.2 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
10.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Market Performance
10.5.4 Merrion Pharmaceuticals Plc. Business Overview
10.5.5 Merrion Pharmaceuticals Plc. Recent Developments
10.6 Ablynx
10.6.1 Ablynx Basic Information
10.6.2 Ablynx Candidiasis Therapeutics Product Overview
10.6.3 Ablynx Candidiasis Therapeutics Product Market Performance
10.6.4 Ablynx Business Overview
10.6.5 Ablynx Recent Developments
10.7 Genta Incorporated
10.7.1 Genta Incorporated Basic Information
10.7.2 Genta Incorporated Candidiasis Therapeutics Product Overview
10.7.3 Genta Incorporated Candidiasis Therapeutics Product Market Performance
10.7.4 Genta Incorporated Business Overview
10.7.5 Genta Incorporated Recent Developments
10.8 Galapagos NV
10.8.1 Galapagos NV Basic Information
10.8.2 Galapagos NV Candidiasis Therapeutics Product Overview
10.8.3 Galapagos NV Candidiasis Therapeutics Product Market Performance
10.8.4 Galapagos NV Business Overview
10.8.5 Galapagos NV Recent Developments
10.9 Catena Pharmaceuticals Inc.
10.9.1 Catena Pharmaceuticals Inc. Basic Information
10.9.2 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
10.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Market Performance
10.9.4 Catena Pharmaceuticals Inc. Business Overview
10.9.5 Catena Pharmaceuticals Inc. Recent Developments
10.10 Digna Biotech S.L.
10.10.1 Digna Biotech S.L. Basic Information
10.10.2 Digna Biotech S.L. Candidiasis Therapeutics Product Overview
10.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product Market Performance
10.10.4 Digna Biotech S.L. Business Overview
10.10.5 Digna Biotech S.L. Recent Developments
10.11 Medivir AB
10.11.1 Medivir AB Basic Information
10.11.2 Medivir AB Candidiasis Therapeutics Product Overview
10.11.3 Medivir AB Candidiasis Therapeutics Product Market Performance
10.11.4 Medivir AB Business Overview
10.11.5 Medivir AB Recent Developments
10.12 Amura Holdings
10.12.1 Amura Holdings Basic Information
10.12.2 Amura Holdings Candidiasis Therapeutics Product Overview
10.12.3 Amura Holdings Candidiasis Therapeutics Product Market Performance
10.12.4 Amura Holdings Business Overview
10.12.5 Amura Holdings Recent Developments
11 CANDIDIASIS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Candidiasis Therapeutics Market Size Forecast
11.2 Global Candidiasis Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Candidiasis Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region
11.2.4 South America Candidiasis Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Candidiasis Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Candidiasis Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Candidiasis Therapeutics by Type (2026-2033)
12.1.2 Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Candidiasis Therapeutics by Type (2026-2033)
12.2 Global Candidiasis Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Candidiasis Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Candidiasis Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Candidiasis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Candidiasis Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Candidiasis Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2024)
Table 10. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Candidiasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Candidiasis Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Candidiasis Therapeutics Sales by Type (K MT)
Table 26. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 27. Global Candidiasis Therapeutics Sales (K MT) by Type (2020-2025)
Table 28. Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Candidiasis Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Candidiasis Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Candidiasis Therapeutics Price (USD/KG) by Type (2020-2025)
Table 32. Global Candidiasis Therapeutics Sales (K MT) by Application
Table 33. Global Candidiasis Therapeutics Market Size by Application
Table 34. Global Candidiasis Therapeutics Sales by Application (2020-2025) & (K MT)
Table 35. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Candidiasis Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Table 38. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 40. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Candidiasis Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 44. North America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 46. Europe Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 50. South America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Candidiasis Therapeutics Production (K MT) by Region(2020-2025)
Table 54. Global Candidiasis Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Novartis AG Basic Information
Table 62. Novartis AG Candidiasis Therapeutics Product Overview
Table 63. Novartis AG Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Novartis AG Business Overview
Table 65. Novartis AG SWOT Analysis
Table 66. Novartis AG Recent Developments
Table 67. Amgen Basic Information
Table 68. Amgen Candidiasis Therapeutics Product Overview
Table 69. Amgen Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Amgen Business Overview
Table 71. Amgen SWOT Analysis
Table 72. Amgen Recent Developments
Table 73. F. Hoffmann-La Roche Ltd. Basic Information
Table 74. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
Table 75. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Ltd. Business Overview
Table 77. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 78. F. Hoffmann-La Roche Ltd. Recent Developments
Table 79. Bayer-Algeta Basic Information
Table 80. Bayer-Algeta Candidiasis Therapeutics Product Overview
Table 81. Bayer-Algeta Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Bayer-Algeta Business Overview
Table 83. Bayer-Algeta Recent Developments
Table 84. Merrion Pharmaceuticals Plc. Basic Information
Table 85. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
Table 86. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merrion Pharmaceuticals Plc. Business Overview
Table 88. Merrion Pharmaceuticals Plc. Recent Developments
Table 89. Ablynx Basic Information
Table 90. Ablynx Candidiasis Therapeutics Product Overview
Table 91. Ablynx Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Ablynx Business Overview
Table 93. Ablynx Recent Developments
Table 94. Genta Incorporated Basic Information
Table 95. Genta Incorporated Candidiasis Therapeutics Product Overview
Table 96. Genta Incorporated Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Genta Incorporated Business Overview
Table 98. Genta Incorporated Recent Developments
Table 99. Galapagos NV Basic Information
Table 100. Galapagos NV Candidiasis Therapeutics Product Overview
Table 101. Galapagos NV Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Galapagos NV Business Overview
Table 103. Galapagos NV Recent Developments
Table 104. Catena Pharmaceuticals Inc. Basic Information
Table 105. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
Table 106. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Catena Pharmaceuticals Inc. Business Overview
Table 108. Catena Pharmaceuticals Inc. Recent Developments
Table 109. Digna Biotech S.L. Basic Information
Table 110. Digna Biotech S.L. Candidiasis Therapeutics Product Overview
Table 111. Digna Biotech S.L. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Digna Biotech S.L. Business Overview
Table 113. Digna Biotech S.L. Recent Developments
Table 114. Medivir AB Basic Information
Table 115. Medivir AB Candidiasis Therapeutics Product Overview
Table 116. Medivir AB Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Medivir AB Business Overview
Table 118. Medivir AB Recent Developments
Table 119. Amura Holdings Basic Information
Table 120. Amura Holdings Candidiasis Therapeutics Product Overview
Table 121. Amura Holdings Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Amura Holdings Business Overview
Table 123. Amura Holdings Recent Developments
Table 124. Global Candidiasis Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Global Candidiasis Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 127. North America Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 129. Europe Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Candidiasis Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 131. Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 133. South America Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Candidiasis Therapeutics Sales Forecast by Type (2026-2033) & (K MT)
Table 137. Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Candidiasis Therapeutics Price Forecast by Type (2026-2033) & (USD/KG)
Table 139. Global Candidiasis Therapeutics Sales (K MT) Forecast by Application (2026-2033)
Table 140. Global Candidiasis Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Candidiasis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Candidiasis Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Candidiasis Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2024)
Table 10. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Candidiasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Candidiasis Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Candidiasis Therapeutics Sales by Type (K MT)
Table 26. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 27. Global Candidiasis Therapeutics Sales (K MT) by Type (2020-2025)
Table 28. Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Candidiasis Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Candidiasis Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Candidiasis Therapeutics Price (USD/KG) by Type (2020-2025)
Table 32. Global Candidiasis Therapeutics Sales (K MT) by Application
Table 33. Global Candidiasis Therapeutics Market Size by Application
Table 34. Global Candidiasis Therapeutics Sales by Application (2020-2025) & (K MT)
Table 35. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Candidiasis Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Table 38. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 40. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Candidiasis Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 44. North America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 46. Europe Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 50. South America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Candidiasis Therapeutics Production (K MT) by Region(2020-2025)
Table 54. Global Candidiasis Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Novartis AG Basic Information
Table 62. Novartis AG Candidiasis Therapeutics Product Overview
Table 63. Novartis AG Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Novartis AG Business Overview
Table 65. Novartis AG SWOT Analysis
Table 66. Novartis AG Recent Developments
Table 67. Amgen Basic Information
Table 68. Amgen Candidiasis Therapeutics Product Overview
Table 69. Amgen Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Amgen Business Overview
Table 71. Amgen SWOT Analysis
Table 72. Amgen Recent Developments
Table 73. F. Hoffmann-La Roche Ltd. Basic Information
Table 74. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
Table 75. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Ltd. Business Overview
Table 77. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 78. F. Hoffmann-La Roche Ltd. Recent Developments
Table 79. Bayer-Algeta Basic Information
Table 80. Bayer-Algeta Candidiasis Therapeutics Product Overview
Table 81. Bayer-Algeta Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Bayer-Algeta Business Overview
Table 83. Bayer-Algeta Recent Developments
Table 84. Merrion Pharmaceuticals Plc. Basic Information
Table 85. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
Table 86. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merrion Pharmaceuticals Plc. Business Overview
Table 88. Merrion Pharmaceuticals Plc. Recent Developments
Table 89. Ablynx Basic Information
Table 90. Ablynx Candidiasis Therapeutics Product Overview
Table 91. Ablynx Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Ablynx Business Overview
Table 93. Ablynx Recent Developments
Table 94. Genta Incorporated Basic Information
Table 95. Genta Incorporated Candidiasis Therapeutics Product Overview
Table 96. Genta Incorporated Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Genta Incorporated Business Overview
Table 98. Genta Incorporated Recent Developments
Table 99. Galapagos NV Basic Information
Table 100. Galapagos NV Candidiasis Therapeutics Product Overview
Table 101. Galapagos NV Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Galapagos NV Business Overview
Table 103. Galapagos NV Recent Developments
Table 104. Catena Pharmaceuticals Inc. Basic Information
Table 105. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
Table 106. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Catena Pharmaceuticals Inc. Business Overview
Table 108. Catena Pharmaceuticals Inc. Recent Developments
Table 109. Digna Biotech S.L. Basic Information
Table 110. Digna Biotech S.L. Candidiasis Therapeutics Product Overview
Table 111. Digna Biotech S.L. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Digna Biotech S.L. Business Overview
Table 113. Digna Biotech S.L. Recent Developments
Table 114. Medivir AB Basic Information
Table 115. Medivir AB Candidiasis Therapeutics Product Overview
Table 116. Medivir AB Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Medivir AB Business Overview
Table 118. Medivir AB Recent Developments
Table 119. Amura Holdings Basic Information
Table 120. Amura Holdings Candidiasis Therapeutics Product Overview
Table 121. Amura Holdings Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Amura Holdings Business Overview
Table 123. Amura Holdings Recent Developments
Table 124. Global Candidiasis Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Global Candidiasis Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 127. North America Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 129. Europe Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Candidiasis Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 131. Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 133. South America Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Candidiasis Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Candidiasis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Candidiasis Therapeutics Sales Forecast by Type (2026-2033) & (K MT)
Table 137. Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Candidiasis Therapeutics Price Forecast by Type (2026-2033) & (USD/KG)
Table 139. Global Candidiasis Therapeutics Sales (K MT) Forecast by Application (2026-2033)
Table 140. Global Candidiasis Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Candidiasis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Candidiasis Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Candidiasis Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Candidiasis Therapeutics Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Candidiasis Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Candidiasis Therapeutics Product Life Cycle
Figure 13. Candidiasis Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Candidiasis Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Candidiasis Therapeutics
Figure 19. Global Candidiasis Therapeutics Market PEST Analysis
Figure 20. Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Candidiasis Therapeutics Market Share by Type
Figure 27. Sales Market Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Candidiasis Therapeutics by Type in 2024
Figure 29. Market Size Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Candidiasis Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Candidiasis Therapeutics Market Share by Application
Figure 33. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Candidiasis Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Candidiasis Therapeutics Market Share by Application in 2024
Figure 37. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Candidiasis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Candidiasis Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Candidiasis Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Candidiasis Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Candidiasis Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Candidiasis Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Candidiasis Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Candidiasis Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Candidiasis Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Candidiasis Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Candidiasis Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Candidiasis Therapeutics Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Candidiasis Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Candidiasis Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Candidiasis Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Candidiasis Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Candidiasis Therapeutics Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Candidiasis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Candidiasis Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Candidiasis Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Candidiasis Therapeutics Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Candidiasis Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Candidiasis Therapeutics Product Life Cycle
Figure 13. Candidiasis Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Candidiasis Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Candidiasis Therapeutics
Figure 19. Global Candidiasis Therapeutics Market PEST Analysis
Figure 20. Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Candidiasis Therapeutics Market Share by Type
Figure 27. Sales Market Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Candidiasis Therapeutics by Type in 2024
Figure 29. Market Size Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Candidiasis Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Candidiasis Therapeutics Market Share by Application
Figure 33. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Candidiasis Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Candidiasis Therapeutics Market Share by Application in 2024
Figure 37. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Candidiasis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Candidiasis Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Candidiasis Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Candidiasis Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Candidiasis Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Candidiasis Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Candidiasis Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Candidiasis Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Candidiasis Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Candidiasis Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Candidiasis Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Candidiasis Therapeutics Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Candidiasis Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Candidiasis Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Candidiasis Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Candidiasis Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Candidiasis Therapeutics Market Share Forecast by Application (2026-2033)
